Boston Common Asset Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,274
Closed -$338K 325
2022
Q4
$338K Buy
1,274
+25
+2% +$6.1K 0.02% 228
2022
Q3
$234K Buy
1,249
+17
+1% +$3.65K 0.01% 245
2022
Q2
$247K Buy
1,232
+110
+10% +$25.8K 0.01% 248
2022
Q1
$338K Sell
1,122
-132
-11% -$38.6K 0.01% 237
2021
Q4
$451K Buy
1,254
+69
+6% +$23.7K 0.02% 216
2021
Q3
$393K Buy
1,185
+9
+0.8% +$3.02K 0.02% 222
2021
Q2
$360K Buy
1,176
+90
+8% +$25.2K 0.02% 228
2021
Q1
$267K Buy
1,086
+15
+1% +$3.77K 0.02% 233
2020
Q4
$292K Buy
+1,071
New +$266K 0.02% 220

Other funds holding ISRG

Boston Common Asset Management's ISRG Position: Q1 2023 in Review

Boston Common Asset Management sold out of Intuitive Surgical (ISRG) in Q1 2023, closing a stake of 1,274 shares — an estimated $338K sold.

Boston Common Asset Management first reported a position in ISRG in Q4 2020 and held it in 9 quarters. The position peaked at $451K in Q4 2021. 1,411 funds tracked by Wall St. Rank hold ISRG as of Q1 2023.

  • Boston Common Asset Management reported no remaining Intuitive Surgical position as of Q1 2023 after selling out during the quarter.
  • Boston Common Asset Management sold 1,274 Intuitive Surgical shares in Q1 2023, an estimated $338K.
  • Boston Common Asset Management first reported a position in Intuitive Surgical in Q4 2020 and held it in 9 quarters.
  • Boston Common Asset Management's Intuitive Surgical position peaked at $451K in Q4 2021.
  • 1,411 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2023.

Based on Boston Common Asset Management's 13F filing for Q1 2023, filed 17 May 2023.